 - The subject has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 30 days, 5 half-lives or twice the duration of the biological effect of the investigational product whichever is longer or has had exposure to more than four new chemical entities within 12 months prior to the first dosing day. 